
The American Kidney Fund (AKF) announced that Pranav Garimella, MBBS, MPH, will be its first chief medical officer (CMO). AKF is a nonprofit that champions kidney health with programs that address early detection, disease management, financial assistance, clinical research, innovation, and advocacy.
Dr. Garimella serves as an attending nephrologist and director of acute dialysis services at the University of California (UC) San Diego Health and is an associate professor of medicine at UC San Diego School of Medicine. He is also co-chair of the Polycystic Kidney Disease Foundation Centers of Excellence Program and recently completed his term as a member of the American Society of Nephrology’s Quality Committee.
Dr. Garimella’s clinical expertise includes a focus on rare kidney conditions such as autosomal dominant polycystic kidney disease. His primary research has focused on novel diagnostic and prognostic biomarkers for kidney disease as well as drug dosing in acute and chronic kidney disease. He also has experience in policy, program development, advocacy, and health care leadership in nephrology.
In his new role, Dr. Garimella will help advance AKF’s 2023-26 strategic plan goal to provide high-level clinical authority and insight to better serve Americans with kidney disease.
Source: Press release